The role of hypoxia related hormones responses in acute mountain sickness susceptibility individuals unaccustomed to high altitude.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 04 10 2022
accepted: 14 09 2023
medline: 1 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: epublish

Résumé

Acute mountain sickness (AMS) is caused by rapid ascent to altitude (>2500 m) and remains a poorly understood pathophysiological condition. Accordingly, we investigated the relationship between acute exposure to high altitude and hypoxia related biochemical proteins. 21 healthy subjects (Female (8) and male (13), Age: 36.7±8.5, BMI: 23.2±3.1) volunteers participated in this project and fasting blood samples were taken before (sea level) and after 1 and 24-h exposure to high altitude (3,550 m). Blood oxygen saturation (SpO2), AMS status (Lake Louise Score) and serum HIF-1, Endothelin-1, VEGF and Orexin-A were measured (via ELISA) at 1, 6 and 24 h after exposure to high altitude. Pre-ascent measurement of hypoxia related proteins (Orexin-A, HIF-1, VEGF and Endothelin-1) where all significantly (<0.05) higher in the AMS-resistant individuals (No-AMS) when compared to AMS susceptible individuals (AMS+). Upon ascent to high altitude, 11 out of 21 volunteers had AMS (10.1±0.6 in AMS+ vs. 0.9±0.6 in No-AMS, P<0.05) and presented with lower resting SpO2 levels (77.7±0.4 vs. 83.5±0.3 respectively, p<0.05). Orexin-A, HIF-1, VEGF and Endothelin-1, significantly increased 24 hrs after exposure to high altitude in both AMS+ and No-AMS. The response of Orexin-A was similar between two groups, also, HIF-1 elevation 24 hrs after exposure to altitude was more in AMS+ (13% vs. 19%), but the increase of VEGF and Endothelin-1, 1 and 24 hrs after exposure to altitude in No-AMS was double that of AMS+. Hypoxia related proteins include Orexin-A, HIF-1, VEGF and Endothelin-1 may play a pathophysiological role in those who are susceptible to AMS.

Identifiants

pubmed: 37796960
doi: 10.1371/journal.pone.0292173
pii: PONE-D-22-27404
pmc: PMC10553285
doi:

Substances chimiques

Endothelin-1 0
Vascular Endothelial Growth Factor A 0
Orexins 0
Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0292173

Informations de copyright

Copyright: © 2023 Fayazi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biochem Biophys Res Commun. 1996 Sep 13;226(2):324-8
pubmed: 8806634
J Occup Environ Med. 2011 Feb;53(2):159-68
pubmed: 21270658
Exp Ther Med. 2014 Jul;8(1):335-339
pubmed: 24944643
J Cereb Blood Flow Metab. 2008 Jan;28(1):198-206
pubmed: 17519973
High Alt Med Biol. 2011 Winter;12(4):323-7
pubmed: 22206557
J Travel Med. 2016 Mar 16;23(3):
pubmed: 26984355
J Mol Neurosci. 2014 Jan;52(1):48-55
pubmed: 24243084
Brain. 2002 Nov;125(Pt 11):2549-57
pubmed: 12390979
High Alt Med Biol. 2016 Mar;17(1):25-31
pubmed: 26680502
Int J Dev Neurosci. 2016 Feb;48:1-8
pubmed: 26548856
Front Physiol. 2017 Feb 08;8:55
pubmed: 28228730
High Alt Med Biol. 2015 Mar;16(1):26-33
pubmed: 25760230
Respiration. 2011;81(3):236-41
pubmed: 21242666
Cell Signal. 2013 Dec;25(12):2413-23
pubmed: 23917208
J Cereb Blood Flow Metab. 2006 Jan;26(1):99-111
pubmed: 15959459
J Appl Physiol (1985). 2011 Aug;111(2):392-9
pubmed: 21636566
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):821-6
pubmed: 11792862
Wilderness Environ Med. 2012 Jun;23(2):114-21
pubmed: 22656656
BMJ Open. 2013 Jul 17;3(7):
pubmed: 23869103
Circulation. 1999 May 25;99(20):2665-8
pubmed: 10338460
Chest. 2000 Jul;118(1):47-52
pubmed: 10893358
J Int Med Res. 2012;40(6):2135-44
pubmed: 23321170
Wilderness Environ Med. 2012 Jun;23(2):122-7
pubmed: 22656657

Auteurs

Bayan Fayazi (B)

Department of Exercise Physiology, Faculty of Sport Sciences, Razi University, Kermanshah, Iran.

Vahid Tadibi (V)

Department of Exercise Physiology, Faculty of Sport Sciences, Razi University, Kermanshah, Iran.

Kamal Ranjbar (K)

Department of Exercise Physiology, Faculty of Sport Sciences, Bandar Abbas Branch, Islamic Azad University, Bandar Abbas, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH